Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thai Patent Authorities Await U.S. Compulsory Licensing Challenge Before WTO

This article was originally published in PharmAsia News

Executive Summary

Thailand's patent authorities say they are bracing for a suit they expect to be filed by the United States before the World Trade Organization over the pharmaceutical compulsory-license dispute. A senior official of the Commerce Ministry says America is preparing a suit that alleges Thailand never discussed with patent holders its plan to abrogate drug patents so generic versions of certain drugs could be sold in the country. Thai officials dispute that claim, saying the government had negotiated with patent owners before compulsory licenses were announced. Drug makers offered only to lower their prices gradually. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel